Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heat Biologics Inc (NASDAQ:HTBX)

0.9724
Delayed Data
As of Dec 09
 -0.0576 / -5.59%
Today’s Change
0.40
Today|||52-Week Range
4.71
-60.15%
Year-to-Date
These Stocks Gained More Than 100% in November
Dec 01 / Zacks.com - Paid Partner Content
Heat Biologics (HTBX) in Focus: Stock Moves 30.4% Higher
Nov 28 / Zacks.com - Paid Partner Content
Heat Biologics Stock Falls on Negative Bladder Cancer Data
Dec 01 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close1.03
Today’s open1.00
Day’s range0.96 - 1.01
Volume1,866,012
Average volume (3 months)2,356,858
Market cap$23.2M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)-38.25%
Earnings growth (this year)+75.30%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.02

Competitors

 Today’s
change
Today’s
% change
PARNParnell Pharmaceutic...-0.00-0.22%
VKTXViking Therapeutics ...+0.01+0.90%
SBOTStellar Biotechnolog...+0.05+2.29%
ABIOARCA Biopharma Inc+0.05+2.13%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateApril 4, 2017
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$0.00
Annual profit (last year)-$20.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeff A. Wolf
Secretary &
Vice President-Finance
Ann A. Rosar
Corporate headquarters
Durham, North Carolina

Forecasts


Search for Jobs